pKL10-mRuby-iATPSnFR1.0 bb118
(Plasmid
#158980)
-
PurposeConstitutive expression (sigma 70 promoter) of the ratiometric mRuby-iATPSnFR1.0 ATP indicator in E. coli.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 158980 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonebb118
- Backbone size w/o insert (bp) 2300
- Total vector size (bp) 4220
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemruby-iATPSNfR1.0
-
SpeciesSynthetic
-
Insert Size (bp)2100
-
Mutationcodon optimized for e. coli from Addgene#102557
- Promoter Bba_J23118 (sigma 70)
-
Tag
/ Fusion Protein
- mruby3
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer tgccacctgacgtctaagaa
- 3′ sequencing primer gctcactcaaaggcggtaat (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byhttps://www.nature.com/articles/s41467-019-08441-5
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
mruby-iATPSnFR was engineered in the paper above, then codon optimized for E. coli on a G-block and cloned into our bb118 backbone to facilitate constitutive expression . Please visit https://doi.org/10.1101/2020.04.23.058362 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pKL10-mRuby-iATPSnFR1.0 bb118 was a gift from Joel Kralj (Addgene plasmid # 158980 ; http://n2t.net/addgene:158980 ; RRID:Addgene_158980) -
For your References section:
Membrane voltage dysregulation driven by metabolic dysfunction underlies bactericidal activity of aminoglycosides. Bruni GN, Kralj JM. eLife. 2020 Aug 4;9. pii: 58706. doi: 10.7554/eLife.58706. 10.7554/eLife.58706 PubMed 32748785